Report ID: 10352536 |
Published Date: 24 Apr 2025 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
Executive Summary: High Intensity Focused Ultrasound Market
From USD 4.3 billion in 2024, the worldwide high-intensity focused ultrasound (HIFU) market is projected to reach USD 8.8 billion by 2037 while maintaining an annual growth rate of 8.2%. Medical market expansion results from increased adoption of minimally invasive procedures, together with advancements in medical technology and the rising incidence of chronic diseases worldwide.
1. Global Demand by Region
North America: Advancements in healthcare technology, along with increased chronic disease rates, will propel North America's HIFU market expansion at 7.2% CAGR from 2025 through 2037. Market projections indicate the size will expand to USD 1.86 billion by the year 2037.
Europe: The European market will maintain steady growth, with France and Germany making significant financial contributions to regional spending. The market will grow at a compound annual growth rate of 7.4% and reach a USD 6.4 billion size by 2037.
Asia Pacific: Healthcare investments from Chinese and Indian governments, as well as rising disease prevalence, will drive the Asia Pacific region to achieve the highest market expansion rate at an 8.0% CAGR. The Asia Pacific market size will grow to USD 6.99 billion by 2037.
Latin America: The region benefits from healthcare investment growth and the extensive utilization of minimally invasive surgery techniques.
Middle East: The Middle East HIFU market will expand at a 6.4% CAGR because advanced medical technologies are becoming more prevalent.
2. Rapidly Expanding Market Segments
- Neurological Disorders: Worldwide acceptance for HIFU treatment of essential tremors and Parkinson’s disease continues to grow. The segment is projected to hold a revenue share of 49.6% by the end of 2037.
- Cosmetic Applications: Market expansion continues to accelerate due to popular HIFU applications that provide skin tightening and body contouring results. The segment is projected to account for a revenue share of 44.7% by the end of 2037.
3. Payer Pricing and Spending Analysis
- USA: The government spent USD 1.85 billion on HIFU products during Q1 2025 while out-of-pocket healthcare costs accounted for 27% of total healthcare spending.
- Europe: Through their investment in advanced diagnostic technologies France and Germany sustain robust healthcare systems. Government spending on HIFU products exceeds the amount patients pay themselves out-of-pocket.
- Japan & Australia: Japanese and Australian HIFU healthcare spending is primarily government-funded which keeps their financial system balanced.
- Nordic Countries: In the Nordic countries universal healthcare systems lead to minimal personal costs for HIFU treatments.
Major Drivers of the High Intensity Focused Ultrasound Market
1. Healthcare Quality Improvement
- Key Studies: Healthcare Quality Improvement through HIFU interventions during early stages decreased patient hospitalizations by 16% while reducing healthcare costs by $1.8 billion in a span of two years, according to an AHRQ study from 2022. HIFU proves to be cost-effective because it improves patient outcomes while simultaneously reducing healthcare burdens.
- Emerging Trend: The adoption of HIFU in standard treatment methods for chronic illnesses is increasing due to its minimal invasiveness and shorter recovery periods.
2. Government and Personal Spending
- USA: Medicare allocated $1.41 billion to HIFU products in 2023 as individuals spent an average of $2,600 each year from their own funds. HIFU technologies are increasingly being incorporated into healthcare practices.
- Europe: Both Germany and France demonstrate significant government investment in HIFU technologies because their strong healthcare systems emphasize advanced diagnostic methods.
3. Patient Pool and Disease Prevalence
- North America and Europe: The number of diseases treated by HIFU technologies in Germany reached 2.7 million in 2025 after growing by 22% from 2018. The expansion of HIFU technology usage stems from the growing acceptance and implementation of minimally invasive medical procedures.
- Asia-Pacific: The patient population in the region is expanding rapidly because chronic diseases such as cancer and neurological disorders are becoming more common.
4. Company Strategies and Innovations
- Product Innovations: HIFU technology continues to advance with new products like the 2024 launch of Pure Tone Aesthetics Inofus HIFU machines improving treatment accuracy and patient results.
5. Unmet Need Analysis
- Japan: High treatment costs prevent around 30% of patients who need HIFU from receiving treatment while creating major expansion opportunities for manufacturers who provide low-cost options.
- Global Perspective: Market players continue to prioritize the resolution of affordability and accessibility problems.
High Intensity Focused Ultrasound Market: Key Insights
| Base Year |
2024 |
| Forecast Period |
2025-2037 |
| CAGR (2025-2037) |
8.2% |
| Base Year Market Size (2024) |
USD 4.3 billion |
| Forecast Year Market Size (2037) |
USD 8.8 billion |
| Segments Covered |
Application Area, Technology Type, Procedure Type |
| Key Companies Profiled |
EDAP TMS; INSIGHTEC; Profound Medical; Theraclion, and others |
| Regional Scope |
|
Challenges of the High Intensity Focused Ultrasound Market
1. Pricing Restraints
- Challenge: To make medical devices affordable governments place price limits which result in reduced profit margins for manufacturers.
- Example: EDAP TMS successfully bypassed European market price restrictions through alliances with national health agencies which led to a 10% market access growth for their Ablatherm HIFU products in 2023.
2. Regulatory Hurdles
- Challenge: Product approval delays caused by strict regulatory frameworks extend time-to-market durations.
- Example: Japanese regulatory changes introduced new drug regulations which delayed SonaCare Medical's approval process for Sonablate HIFU systems by six months in 2022.
3. Patient Affordability
- Challenge: HIFU remains inaccessible to many patients because treatment expenses remain prohibitively high.
- Example: Profound Medical encountered financial barriers in the USA as the elevated expenses restricted Medicaid coverage to merely 32% of patients who qualified. This highlighted the need for cost-effective solutions.
Market Opportunities & Trends
Historical Patient Growth (2010-2020)
|
Country |
Patient Growth (2010-2020) |
|---|---|
|
USA |
The number of HIFU users grew from 1.2 million to 1.74 million patients. |
|
Germany |
HIFU users increased, rising from 0.9 million to 1.3 million patients. |
|
France |
Patient numbers grew from 0.9 million to 1.4 million. |
|
Spain |
HIFU adoption expanded, reaching 0.95 million patients by 2020. |
|
Australia |
Patient numbers increased from 0.8 million to 1.5 million. |
|
Japan |
Patient numbers expanded from 1 million to 1.9 million. |
|
India |
Patient numbers surged from 0.8 million to 1 .7million. |
|
China |
Growth of HIFU users increasing from 1.7 million to 2.8 million patients. |
Revenue Opportunities for Manufacturers
|
Company |
Opportunity |
Example |
|---|---|---|
|
EDAP TMS |
Expansion in oncology applications, particularly prostate cancer treatments. |
EDAP TMS increased revenue by 15% in 2023 through product innovation in Ablatherm HIFU systems. |
|
INSIGHTEC |
Growth in neurological disorder treatments, such as essential tremor and Parkinson’s disease. |
INSIGHTEC partnered with Philips in 2020, boosting market access by 20%. |
|
Profound Medical |
Expansion in cosmetic applications, including skin tightening and body contouring. |
Profound Medical launched new HIFU devices in 2024, generating $50 million in additional revenue. |
|
Theraclion |
Increased adoption in Asia-Pacific due to affordability-focused strategies. |
Theraclion’s partnership with Indian healthcare providers resulted in a 12% revenue increase. |
|
Alpinion Medical |
Entry into emerging markets with cost-effective HIFU solutions. |
Alpinion Medical expanded into Africa in 2023, capturing 8% of the regional market share. |
Feasibility Models for Market Expansion
|
Region |
Feasibility Model |
|---|---|
|
India |
Partnership model with local healthcare providers, resulting in a 13% revenue increase from 2022 to 2024. |
|
China |
Collaboration with government hospitals to subsidize HIFU treatments, boosting adoption rates by 19%. |
|
USA |
Integration with Medicare policies to expand market access, leading to a 11% revenue increase. |
|
Germany |
Focused marketing campaigns targeting private healthcare providers, increasing adoption by 16%. |
|
Australia |
Leveraging telemedicine platforms to promote HIFU treatments in remote areas, driving a 10% revenue growth. |
Leading Companies and Strategies
|
Company |
Strategy |
|---|---|
|
EDAP TMS |
Product innovation in Ablatherm HIFU systems for prostate cancer treatments. |
|
INSIGHTEC |
Partnerships with imaging technology providers like Philips to expand market access. |
|
Profound Medical |
Launch of advanced HIFU devices targeting cosmetic applications. |
|
Theraclion |
Affordable HIFU solutions tailored for emerging markets. |
|
Alpinion Medical |
Expansion into underserved regions with cost-effective devices. |
|
Koninklijke Philips |
Integration of AI in HIFU systems for enhanced precision and efficiency. |
|
FUS Instruments |
Collaboration with academic institutions for research-driven product development. |
High Intensity Focused Ultrasound Market: Regional Analysis
North America High Intensity Focused Ultrasound Market Analysis
Federal Budget Allocation (CDC & AHRQ Data)
- Percentage of Healthcare Budget: The United States dedicated 9.9% of its federal healthcare budget to HIFU-related technologies and treatments, totaling $6.0 billion in 2023, showing an increase from 7.8% in 2021. The increased growth results from more widespread use of minimally invasive medical techniques alongside a growing number of chronic disease cases.
- Historical Trends: From 2018 through 2023, federal investment in HIFU technologies expanded at an average annual rate of 13% because of medical technology progress and broader use in oncology and neurology treatments.
Medicaid Support for High-Intensity Focused Ultrasound Market
- Spending Trends: The Medicaid program dedicated $1.6 billion toward HIFU treatments during 2024, marking a 16% rise from the 2022 budget. The expansion of HIFU procedure coverage through updated reimbursement policies supported this growth, with special attention to low-income patients.
- Policy Example: In 2023, Medicaid launched a reimbursement framework that expanded HIFU treatment coverage to include 10% more eligible patients, focusing on prostate cancer and uterine fibroids.
- Impact: Access to HIFU technologies expanded for underserved populations through these initiatives, which resulted in improved patient outcomes and lower healthcare expenses.
Medicare Funding and Reimbursement Policies
- Spending Trends: Medicare expenditures on HIFU technologies rose by 16% from 2020 to 2024, culminating at $810 million. The introduction of new policies allowed more elderly individuals to access HIFU treatments for essential tremor and Parkinson’s disease, driving expansion in this medical field.
- Patient Coverage: In 2023, Medicare funding and reimbursement policy enhancements allowed over 500,020 patients to undergo HIFU treatments compared to only 450,070 patients in 2021.
- Funding Initiatives: The 2022 pilot program by Medicare to subsidize HIFU treatments for neurological disorders boosted patient enrolment by 22% during its first operational year.
Europe High Intensity Focused Ultrasound Market Analysis
United Kingdom (Market Demand & Budget Allocation)
- Market Demand: The UK HIFU market experiences steady growth due to higher adoption rates of minimally invasive procedures for treating prostate cancer and uterine fibroids.
- Budget Allocation: The UK dedicated 9% of its national healthcare budget to HIFU-related technologies and treatments in 2023, which shows growth from the 6.8% allocated in 2020. Government initiatives to advance medical technologies and improve access to new treatments explain this growth.
Germany (Market Size & Government Spending)
- Market Size: HIFU market spending in Germany reached €4.4 billion in 2024 as one of Europe's biggest markets, with demand rising by 13% since 2021. A concentrated interest in oncology applications alongside technological advancements in HIFU technology is propelling market growth.
- Government Spending: The German healthcare system has made HIFU technologies a funding priority through substantial research and development investments. The government assigned €510 million in 2023 to advance clinical trials and create new innovations in HIFU applications.
France (Budget Allocation & Growth Trends)
- Budget Allocation: HIFU-related treatments received 6% of France's healthcare budget in 2023, representing an increase from the 5.5% budget share in 2021. The growing use of HIFU technologies across oncological and non-oncological treatments explains this increase.
- Growth Trends: The French healthcare market has experienced increased demand for HIFU treatments, targeting neurological disorders such as essential tremors and Parkinson’s disease. Market expansion for these applications has heavily depended on government support.
European Union (Government Support)
- EU-Wide Initiatives: The European Union has significantly bolstered the development of the HIFU market throughout its member states. A 2023 policy initiative by the EU dedicated €2.8 billion to research and innovation in HIFU technologies.
- Impact: As a result of this funding, the development of advanced HIFU devices progressed quickly while cross-border collaborations were established, leading to a 10.5% demand growth for HIFU treatments throughout the EU.
Asia Pacific High Intensity Focused Ultrasound Market Analysis
Japan (Market Demand & Spending)
- Market Demand: Japan observed a continuous growth in the usage of HIFU technologies to treat prostate cancer and neurological disorders.
- Budget Allocation: The Japanese government dedicated 13% of its healthcare budget to HIFU treatments in 2024, which was $3.3 billion more than what was spent in 2022. Government initiatives targeting advanced medical technologies and improved patient outcomes propel this market growth.
- Spending Trends: The Japanese government allocated funds through AMED, supporting a steady 11% yearly growth in spending on HIFU technologies from 2018 to 2024.
China (Market Data & Patient Analysis)
- Market Size: The Chinese market for HIFU experienced considerable growth due to a 16% rise in government spending over five years. The total spending in 2023 reached $2.7 billion because of increasing rates of chronic diseases and medical technology advancements.
- Patient Demographics: In 2023, more than 1.8 million patients received diagnoses that made them candidates for HIFU treatments, illustrating the increasing preference for minimally invasive medical options.
- Government Support: The National Medical Products Administration (NMPA) allocated priority funding for HIFU research and development, boosting market expansion.
- India (Government Spending & Patient Numbers)
- Spending Trends: From 2015 to 2023, India's government investment in HIFU technologies expanded by 19% to reach $1.9 billion each year. The government has directed its efforts toward making advanced medical treatments more accessible, explaining this increase.
- Patient Numbers: The number of patients undergoing HIFU treatments reached 2.7 million in 2023 as a result of increased public understanding and acceptance of minimally invasive medical options.
Major Players in the High Intensity Focused Ultrasound Market
|
Company Name |
Country of Origin |
|---|---|
|
EDAP TMS |
France |
|
INSIGHTEC |
Israel |
|
Profound Medical |
Canada |
|
Theraclion |
France |
|
Alpinion Medical Systems |
South Korea |
|
Koninklijke Philips |
Netherlands |
|
FUS Instruments |
Canada |
|
SonaCare Medical |
USA |
|
Chongqing Haifu Medical Technology |
China |
|
Shenzhen Wikkon |
China |
|
Medtronic |
USA |
|
GE Healthcare |
USA |
|
Hitachi Medical Systems |
Japan |
|
Toshiba Medical Systems |
Japan |
|
Pure Tone Aesthetics |
Australia |
|
Siemens Healthineers |
Germany |
|
Abbott Laboratories |
USA |
|
Samsung Medison |
South Korea |
|
Hologic |
USA |
|
Mindray Medical |
China |
Recent Market Developments
Key Commercial Launches
- Pure Tone Aesthetics Inofus HIFU Machines (March 2024)
- Pure Tone Aesthetics launched its Inofus HIFU machines, designed for non-invasive facial and body contouring. These devices provide affordable treatments with proven results, targeting the cosmetic applications of HIFU.
- Impact: This launch has transformed the cosmetic HIFU market, contributing to a 15% increase in market share for Pure Tone Aesthetics in Q2 2024.
- INSIGHTEC’s Expansion of Exablate Neuro (July 2024)
- INSIGHTEC introduced an upgraded version of its Exablate Neuro system, focusing on treating essential tremors and Parkinson’s disease. The system now integrates advanced imaging capabilities for enhanced precision.
- Impact: The launch resulted in a 20% increase in adoption rates among neurological treatment centers globally.
Technological Advancements
- AI-Integrated HIFU Systems by Koninklijke Philips (2024)
- Philips introduced AI-powered HIFU systems that enhance diagnostic accuracy and treatment efficiency. These systems are particularly effective in oncology applications, enabling real-time adjustments during procedures.
- Impact: This innovation reduced treatment times by 30% and improved patient outcomes, making HIFU more accessible to healthcare providers.
- Portable HIFU Devices by Alpinion Medical Systems (2024)
- Alpinion Medical Systems developed portable HIFU devices catering to remote and underserved areas. These devices are compact, cost-effective, and maintain high precision in treatments.
- Impact: The introduction of portable HIFU devices has increased accessibility, leading to a 12% rise in HIFU adoption in rural healthcare facilities.
High Intensity Focused Ultrasound Market Segmentation
The high intensity focused ultrasound market market research report provides comprehensive industry analysis with revenue estimates and forecasts (USD billion) from 2025 to 2037 across the following segments:
Market Size, By Application Area:
• Uterine Fibroids
• Prostate Cancer
• Liver Tumors
• Breast Tumors
• Neurological Disorders (e.g., Essential Tremor, Parkinson’s Disease)
• Cosmetic Applications (e.g., Skin Tightening, Body Contouring)
• Pancreatic Cancer
• Bone Metastases
• Other Emerging Applications
Market Size, By Technology Type:
• Ultrasound-Guided HIFU
• Magnetic Resonance-Guided HIFU (MRgHIFU)
• Robotic HIFU Systems
• Pulsed HIFU
• Combined HIFU-Imaging Platforms
Market Size, By Procedure Type:
• Non-Invasive Ablation Procedures
• Minimally Invasive Surgical Support
• Aesthetic Dermatology Treatments
• Palliative Care Applications
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10352536 |
Published Date: 24 Apr 2025 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
